Searched for
PHARMACEUTICALS GROWTH
India's CDMO industry set for global shift as pharma diversifies beyond China: Sai Life SciencesIndian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...- Sensex jumps over 700 points, Nifty rises above 24,200 as oil prices cool below $73 per barrelOn Thursday, Indian stock markets experienced a remarkable surge, with both Sensex and Nifty seeing significant gains as oil prices fell be...
- Forget power: The unquenchable AI thirst propelling water stocks up to 45%India's water sector is experiencing a surge, with stocks like Shakti Pumps and VA Tech Wabag jumping up to 45% in a month. This rally is f...
- India-Latin America trade to reach $100 billion by 2030 from $50 billion currently: Uruguay AmbassadorAmarilla, Ambassador of Uruguay to India and Coordinator of the Latin American and Caribbean Group (GRULAC), told ANI on Wednesday, highlig...
- Nominal GDP growth could fuel largecap recovery; pharma, auto ancillaries remain preferred bets: Shreyash DevalkarIndian stock markets are defying foreign investor caution, driven by resilient June-quarter earnings. Companies are navigating geopolitical...
- Diksha Polymers shares list at 2% premium to IPO price on BSE SME platformDiksha Polymers debuted on the BSE SME platform at a slight premium, opening at Rs 114.50 against its IPO price of Rs 112. The Rs 17.9-cror...
- India's services exports narrow gap with goods trade as overall trade grows 5.4% in Q4FY26: NITI AayogIndia's trade saw a healthy 5.4% growth in Q4 FY26, driven by robust services exports that significantly boosted the services trade surplus...
- India's pharma supply chain remains 65 per cent dependent on China for critical inputs: NITI AayogIndia's pharmaceutical sector, despite being the "pharmacy of the world," faces significant reliance on China for raw materials, with nearl...
- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
- Cipla shares jump 4% as Citi puts stock on 90-day catalyst watch. What's driving the optimism?Cipla's stock surged following Citi's 'Buy' rating and a 90-day Positive Catalyst Watch. The brokerage anticipates growth from potential US...
- Banking, capital goods and midcaps seen driving market's next rally: Ashish ChaturmohtaIndian equities are poised for fresh highs, driven by strong earnings and sector-specific momentum, particularly in financials and manufact...
- Smaller cities power India’s corporate travel surgeCorporate travel in India is increasingly shifting towards smaller cities, with nearly 60% of bookings now originating from or heading to t...
- Aurobindo Pharma US gets FTC nod for $250 million acquisition of Lannett CompanyAurobindo Pharma's US arm has secured Federal Trade Commission approval for its $250 million acquisition of Lannett Company. This strategic...
- Stocks in news: Sun Pharma, Tech Mahindra, Tata Motors, Voltas, ONGCIndian markets saw a dip on Friday, with IT stocks leading the decline. Analysts suggest profit-taking occurred near the 24,150 mark. Despi...
- Forget AI and EVs: Zerodha’s Nikhil Kamath spots next big billion-dollar opportunity hidden in India’s biggest problemNikhil Kamath water business idea: India's rapid growth in water-intensive sectors like agriculture, nuclear energy, pharmaceuticals, and d...
- Aurobindo Pharma clears key US hurdle in Lannett acquisition, closing expected soonIndian drug giant Aurobindo Pharma is set for a major US expansion. The company has received crucial antitrust clearance from the US Federa...
- Odisha govt approves 20 mega investment proposals worth Rs 76,612 croreOdisha's government has approved 20 mega investment proposals totaling Rs 76,612 crore, projected to create over 50,000 jobs. These signifi...
- Indian pharma market's double-digit growth momentum is likely to continue further: EquirusThe Indian Pharmaceutical Market is set for continued double-digit growth. May's performance showed strong demand across all therapies. Chr...
- Share of services in exports rises to 48.8% in FY26India's services exports have seen significant growth. The services sector now accounts for nearly half of the country's total exports. Thi...
- India's structural growth story remains strong despite global uncertainties: VenturaIndia's long-term growth outlook remains robust despite global geopolitical uncertainties and intermittent market volatility, supported by ...
Load More
